Closing Bell: Nervgen Pharma Corp down on Tuesday (NGEN)

Today in trading, Nervgen Pharma Corp shares opened at $2.90 and closed at $2.90. It traded at a low of $2.88 to a high of $3.00.

Shares dipped -0.68 percent from the previous day's close of $2.92.

Today across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

Trading volume was 82,221 on 217 total trades, while having an average volume of 49,032 in the last five days.

The TSX-V overall saw 3,093 price advancers against 2,137 declines and 96 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 52 weeks, Nervgen Pharma Corp's shares have advanced 67.63%, while this year, they have advanced 7.41%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $204.19 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..